Phytronix and Agilent to Co-Market Phytronix LDTD Ion Source with Agilent Mass Spectrometers
News Jun 10, 2009
Phytronix Technologies Inc. and Agilent Technologies Inc. announced they have signed a non-exclusive co-marketing agreement to promote the Phytronix Laser Diode Thermal Desorption (LDTD) Ion Source with Agilent mass spectrometers.
The LDTD Ion Source, used with an Agilent MS/MS can offer ultra fast sample analysis for both quantitative and qualitative applications in high-throughput environments such as drug discovery processes (ADMET and DMPK), toxicology, forensics, food safety, and environmental applications.
The LDTD complements Agilent’s 1200 Series HPLC-Chip/MS. The latter provides on-line LC/MS at nanoflow rates that are well-suited to applications where sample amount is limited. The LDTD is based on a shotgun approach, which uses the separation power of the mass spectrometer for high throughput small molecule quantization in a myriad of applications.
Agilent and Phytronix have co-developed the interface between the LDTD and Agilent mass spectrometers to provide life science users with throughput that can exceed 20,000 samples per week.
Under the agreement, the companies will co-market the LDTD and Agilent mass spectrometer systems with each company responsible for its individual products. Agilent will sell and support its mass spectrometers and Phytronix will sell and support the LDTD and the interface between the LDTD and Agilent mass spectrometers. Each company will co-promote their products at industry tradeshows and conferences.
“The combination of the LDTD with Agilent mass spectrometers provides a powerful tool for life science researchers,” said Jean Lacoursiere, Phytronix’s President.
“In particular the LDTD combined with the new Agilent 6530 Accurate-Mass Q-TOF and 6460 Triple Quadrupole instruments provides researchers with exceptional sensitivity and analytical speed. This LDTD-Agilent mass spectrometer system allows, for example, pharmacokinetic studies in less than 10 minutes as well as enzyme inhibition trials in 18 minutes rather than the 10 hours presently required with current methods of analysis.”
Ken Miller, Global Sr. Marketing Manager for Mass Spectrometry at Agilent, added, “The Phytronix LDTD system will be very complementary to the Agilent nanoflow HPLC-Chip technology. The LDTD ion source offers some added capabilities such as a run-time of 4 seconds per sample for high throughput analysis. Many of our customers have asked for the integration of the Phytronix system with our 6000 Series LC/MS products, especially the Agilent 6400 Series Triple Quadrupole LC/MS/MS system.”
'Body-on-a-Chip' Could Advance Drug EvaluationNews
MIT engineers have developed new technology that could be used to evaluate new drugs and detect possible side effects before the drugs are tested in humans. Using a microfluidic platform that connects engineered tissues from up to 10 organs, the researchers can accurately replicate human organ interactions for weeks at a time.READ MORE
Hope for Hot Flushes: New Class of Menopause Drugs Reduces SeverityNews
A new class of experimental drugs reduces hot flushes in menopausal women by almost three-quarters in just three days. The new analysis, published in the journal Menopause, also revealed sleep and concentration significantly improved in the three-day window.
Study Debunks Fears of Increased Teen Suicide Risk From TamifluNews
Researchers from the University of Illinois at Chicago suggests that the drug oseltamivir - commonly known as Tamiflu - does not cause an increased risk of suicide in pediatric patients.READ MORE